Fig. 3
From: Novel heavily fucosylated glycans as a promising therapeutic target in colorectal cancer
a–c Western blot analysis of HFGs by anti-HFG mAb in NAT and tumor tissues of 18 patients with CRC. CRC colorectal cancer, HFG heavily fucosylated glycan, IHC immunohistochemistry, N normal tissue adjacent to tumor, T tumor tissue; AGS, cells with high expression of HFGs that can be recognized by anti-HFG mAb (positive control); MKN45, cells without the expression of HFGs (negative control)